Acura Pharmaceuticals Inc.

Ron Spivey has been Senior Scientific Advisor since January 1, 2009. He previously was Senior Vice President and Chief Scientific Officer since April, 2004. From June, 2003 to March, 2004 Dr. Spivey was President of Gibraltar Associates, a private company providing consulting services to the pharmaceutical industry relating to product research and development. From March, 1998 to May, 2002 he served as Vice President, Scientific Affairs for Alpharma / Purepac Pharmaceuticals. Additionally, Dr Spivey has served in a number of senior level scientific and leadership positions at Zenith Goldline Pharmaceuticals, Cima Labs Inc., Marion Merrell Dow, Burroughs Wellcome Company and Warner Chilcott Division of Warner Lambert. Dr. Spivey holds a BA degree from Indiana University and a Ph.D. degree in pharmaceutics from the University of Iowa.

Albert W. Brzeczko, Ph.D., has been Vice President, Technical Affairs since February 2009. From 1999 through 2009, Dr. Brzeczko was Vice President, Global Pharma New Product Development and Pharma Technologies for International Specialty Products, Inc., a contract services group specializing in the development of technologies for the bioenhancement of poorly soluble drugs. Prior to 1999, Dr. Brzeczko held various positions of increasing responsibility in pharmaceutical product development with UPM Pharmaceuticals, Banner Pharmacaps, Mylan Laboratories, and DuPont Merck. Dr. Brzeczko received a Bachelor of Science degree in biochemistry and a Ph.D. in pharmaceutical sciences from the University of Maryland.

Garth Boehm, Ph.D., is our Vice President of Modified Release Dosage Form Development commencing May 11, 2009. From 2005 to April 2008, Dr. Boehm was Vice President of Product Development at Actavis Pharmaceuticals. From May 2004 to 2005 he served as Senior Vice President and Chief Scientific Officer for Able Laboratories, Inc., a pharmaceutical company and from October 1996 until April 2004 Dr. Boehm was Vice President, Product Development for Purepac Pharmaceutical Company. Dr. Boehm received a Bachelor of Science degree in physical and inorganic chemistry and a Ph.D. in physical and inorganic chemistry from the University of Adelaide, Australia. Age 59.

Bob Seiser has been Vice President, Treasurer and Corporate Controller since April 2004. Prior to that time, Mr. Seiser was the Company's Treasurer and Corporate Controller. From 1992 until joining the Company in March 1998, Mr. Seiser served as Treasurer and Corporate Controller of TC Manufacturing Co., Inc., a privately held company based in Evanston, Illinois, which through its various subsidiaries and divisions, manufactured generic pharmaceuticals, industrial coatings and flexible packaging. Bob is a Certified Public Accountant, was employed at KPMG Peat Marwick - Chicago, and earned a B.B.A. degree from Loyola University of Chicago.

Immanuel Thangaraj has been a director of Acura since December, 2002. Mr. Thangaraj has been a Managing Director of Essex Woodlands Health Ventures, a venture capital firm specializes in the healthcare industry, since 1997. He serves as a director of private companies. Prior to joining Essex Woodlands Health Ventures, he helped establish a telecommunication services company, for which he served as its CEO. Mr. Thangaraj holds a Bachelor of Arts and a Masters in Business Administration from the University of Chicago.

Bill Skelly has been a director of Acura since May, 1996 and was Chairman of Acura from October, 1996 through June, 2000. Since 1990, Mr. Skelly has served as Chairman, President and Chief Executive Officer of Central Biomedia, Inc. and its subsidiary Sera, Inc. These companies are involved in the animal health industry including veterinary biologicals and custom manufacturing of animal sera products. From 1985 to 1990, Mr. Skelly served as President of Martec Pharmaceutical, Inc., a distributor and manufacturer of human generic prescription pharmaceuticals. Mr. Skelly holds a B.A. degree from Michigan State University and a Masters in Business Administration from the University of Missouri-Kansas City.

Bill Sumner has been a director of Acura since August, 1997. From 1974 until his retirement in 1995, Mr. Sumner held various positions at Hoechst-Roussel Pharmaceuticals, Inc., a manufacturer and distributor of pharmaceutical products, including Vice President and General Manager, Dermatology Division from 1991 through 1995, Vice President, Strategic Business Development, from 1989 to 1991 and Vice President, Marketing from 1985 to 1989. Since his retirement from Hoechst-Roussel Pharmaceuticals, Inc. Mr. Sumner has been a consultant to the pharmaceutical industry. Mr. Sumner holds a B.A. degree from Montclair State University and a Master of Arts from the University of Virginia.